This company has been marked as potentially delisted and may not be actively trading. Karuna Therapeutics (KRTX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock KRTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Karuna Therapeutics’ Phase 3 Study on KarXT: A Potential Game-Changer for Alzheimer’s PsychosisAugust 12, 2025 | tipranks.comKaruna Therapeutics’ Phase 3 Study on KarXT: A Potential Game-Changer for Alzheimer’s PsychosisJuly 17, 2025 | tipranks.comKaruna Therapeutics’ Phase 3 Study on KarXT: A Potential Game-Changer for Alzheimer’s PsychosisJuly 4, 2025 | tipranks.comKaruna Therapeutics Advances Alzheimer’s Psychosis Treatment with KarXT StudyJune 27, 2025 | tipranks.comThis FDA-approved drug promises a new way to treat schizophreniaSeptember 30, 2024 | msn.comBMS wins approval for schizophrenia drug acquired from KarunaSeptember 27, 2024 | msn.comBristol Myers to Purchase KarunaSeptember 13, 2024 | msn.comS&P 500 Q1 earnings estimated growth improves; stocks up for weekApril 26, 2024 | investing.comBristol Myers posts quarterly loss, lays out $1.5 billion cost-saving planApril 25, 2024 | investing.comAfter Karuna's acquisition, former CEO lands new gig at Cambridge biotechApril 22, 2024 | bizjournals.comSeaport Therapeutics has $100 million to develop new ways to treat mental disordersApril 9, 2024 | msn.comChina Universal Asset Management Co. Ltd. Purchases 3,392 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)April 4, 2024 | marketbeat.comKaruna Therapeutics, Inc. (NASDAQ:KRTX) Given Average Rating of "Hold" by AnalystsApril 4, 2024 | marketbeat.comKaruna Therapeutics, Inc. (NASDAQ:KRTX) Stock Position Raised by SG Americas Securities LLCMarch 24, 2024 | marketbeat.comDeutsche Bank AG Buys 7,282 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)March 21, 2024 | marketbeat.comKaruna Therapeutics (NASDAQ:KRTX) Given Neutral Rating at HC WainwrightMarch 18, 2024 | marketbeat.comKaruna Therapeutics (NASDAQ:KRTX) Sets New 1-Year High at $329.99March 18, 2024 | marketbeat.comKaruna Therapeutics, Inc. (NASDAQ:KRTX) Sees Significant Decrease in Short InterestMarch 18, 2024 | marketbeat.comKaruna Therapeutics (Nasdaq:KRTX) HeadlineTrading was temporarily halted for "KRTX" at 07:03 PM with a stated reason of "News pending."...March 18, 2024 | marketbeat.comQ1 2024 EPS Estimates for Karuna Therapeutics, Inc. (NASDAQ:KRTX) Reduced by Zacks ResearchMarch 18, 2024 | marketbeat.comHudson Bay Capital Management LP Takes Position in Karuna Therapeutics, Inc. (NASDAQ:KRTX)March 16, 2024 | marketbeat.comCatalyst Private Wealth LLC Grows Stock Position in Karuna Therapeutics, Inc. (NASDAQ:KRTX)March 15, 2024 | marketbeat.comLoss-Making Karuna Therapeutics, Inc. (NASDAQ:KRTX) Expected To Breakeven In The Medium-TermMarch 15, 2024 | finance.yahoo.comZacks Research Weighs in on Karuna Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:KRTX)March 15, 2024 | marketbeat.comKRTX May 2024 210.000 callMarch 15, 2024 | ca.finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Karuna Therapeutics (KRTX) and Cannabist Company Holdings (OtherCBSTF)March 14, 2024 | markets.businessinsider.comKaruna Therapeutics (NASDAQ:KRTX) Hits New 1-Year High at $321.80March 12, 2024 | marketbeat.comKaruna Therapeutics, Inc. (NASDAQ:KRTX) Insider Sells $1,591,700.00 in StockMarch 12, 2024 | insidertrades.comEnvestnet Asset Management Inc. Has $3.41 Million Stock Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)March 11, 2024 | marketbeat.comNorthern Trust Corp Raises Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)March 9, 2024 | marketbeat.comBronte Amalthea Fund Incurred Loss in Karuna Therapeutics (KRTX) Short PositionMarch 4, 2024 | finance.yahoo.comHsbc Holdings PLC Makes New $2.03 Million Investment in Karuna Therapeutics, Inc. (NASDAQ:KRTX)March 2, 2024 | marketbeat.comAvidity Partners Management LP Sells 155,500 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)February 27, 2024 | marketbeat.comKaruna Therapeutics drops on no apparent news amid deal with Bristol-Myers SquibbFebruary 26, 2024 | msn.comInvesco Ltd. Cuts Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)February 26, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Position in Karuna Therapeutics, Inc. (NASDAQ:KRTX)February 25, 2024 | marketbeat.comKaruna Therapeutics (NASDAQ:KRTX) Releases Earnings Results, Misses Estimates By $0.36 EPSFebruary 23, 2024 | marketbeat.com1KRTX : Karuna Therapeutics: Q4 Earnings InsightsFebruary 23, 2024 | benzinga.comAigen Investment Management LP Acquires Shares of 2,275 Karuna Therapeutics, Inc. (NASDAQ:KRTX)February 23, 2024 | marketbeat.comKaruna Therapeutics GAAP EPS of -$3.01 misses by $0.29February 22, 2024 | msn.comKaruna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business UpdateFebruary 22, 2024 | finance.yahoo.comKaruna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business UpdateFebruary 22, 2024 | businesswire.comBronte Capital - Karuna Therapeutics: A Rare Mistake With A Natural Test Of ProcessFebruary 21, 2024 | seekingalpha.comDeutsche Bank AG Increases Stock Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)February 21, 2024 | marketbeat.comMutual of America Capital Management LLC Has $1.29 Million Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)February 20, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 32,548 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)February 19, 2024 | marketbeat.comKaruna Therapeutics: Getting Sold ShortFebruary 18, 2024 | seekingalpha.comFmr LLC Acquires 33,579 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)February 18, 2024 | marketbeat.comKRTX Mar 2024 320.000 callFebruary 17, 2024 | finance.yahoo.comKRTX Mar 2024 260.000 putFebruary 17, 2024 | finance.yahoo.com Get Karuna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KRTX Media Mentions By Week KRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRTX News Sentiment▼0.000.63▲Average Medical News Sentiment KRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRTX Articles This Week▼00▲KRTX Articles Average Week Get the Latest News and Ratings for KRTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Karuna Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MENS News MOR News ZYME News MBX News AVTE News BIOA News CYBN News VIRI News OSTX News ELYM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRTX) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karuna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Karuna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
